Agreement between two commercially available SARS-CoV-2 serologic tests among Italian healthcare workers

Epidemiol Prev. 2021 Jan-Apr;45(1-2):5-6. doi: 10.19191/EP21.1-2.P005.027.

Authors

Lucia Barcellini^{1

2}, Antonella Amendola^{3

4

2}, Elisabetta Tanzi^{5

4}, Laura Folgori¹, Silvia Bianchi⁵, Maria Gori⁵, Daniela Colzani⁵, Emma Longoni¹, Gian Vincenzo Zuccotti¹

Affiliations

¹ Department of Paediatrics, Children's Hospital V. Buzzi, University of Milan, Milan (Italy).
² Joint last authors.
³ Department of Biomedical Sciences for Health, University of Milan, Milan (Italy); antonella.amendola@unimi.it.
⁴ Coordinated Research Centre "EpiSoMI", University of Milan, Milan (Italy).
⁵ Department of Biomedical Sciences for Health, University of Milan, Milan (Italy).

PMID: 33884831
DOI: 10.19191/EP21.1-2.P005.027

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Serological Testing*
COVID-19* / diagnosis
COVID-19* / epidemiology
Health Personnel*
Humans
Italy / epidemiology
Reproducibility of Results